期刊論文1. | 丁志音(19990400)。醫師如何看待醫院的企業化經營管理趨勢。中華公共衛生雜誌,18(2),152-166。 延伸查詢 |
2. | McArthur, J. H.、Moore, F. D.(1997)。The two cultures and the health care revolution: Commerce and professionalism in medical care。JAMA,277,985-989。 |
3. | Miller, F. G.、Brody, H.(2005)。Enhancement technologies and professional integrity。Am J Bioethics,5,15-17。 |
4. | Bostrom, Nick(2005)。In Defense of Posthuman Dignity。Bioethics,19(3),202-214。 |
5. | Conrad, Peter(1975)。The Discovery of Hyperkinesis: Notes on the Medicalization of Deviant Behavior。Social Problems,23(1),12-21。 |
6. | Lexchin, J.(2006)。Bigger and Better: How Pfizer Redefined Erectile Dysfunction。PLoS Medicine,3,132。 |
7. | Kapiriri, L.、Martin, D. K.(2007)。Bedside Rationing by Health Practitioners: A Case Study in a Ugandan Hospital。Medical Decision Making,27,44-52。 |
8. | Parens, E.(2005)。Authenticity and Ambivalence: Toward Understanding the Enhancement Debate。The Hastings Center Report,35,34-41。 |
9. | Emanuel, L.(1997)。Bringing Market Medicine to Professional Account。JAMA: The Journal of the American Medical Association,277,1004-1005。 |
10. | Mehlman, M. J.(2004)。Cognition-enhancing Drugs。The Milbank Quarterly,82,483-506。 |
11. | WHO(2006)。Counterfeit Medicines。WHO Drug Information,20,3-4。 |
12. | Ashworth, M.、Clement, S.、Wright, M.(2002)。Demand, Appropriateness and Prescribing of 'Lifestyle Drugs': A Consultation Survey in General Practice。Family Practice,19,236-241。 |
13. | Mansfield, P. R.、Mintzes, B.、Richards, D.(2005)。Direct to Consumer Advertising Is at the Crossroads of Competing Pressures from Industry and Health Needs。British Medical Journal,330,5-6。 |
14. | Hoffman, J. R.、Wilkes, M.(1999)。Direct to Consumer Advertising of Prescription Drugs: An Idea Whose Time Should Not Come。British Medical Journal,318,1301-1302。 |
15. | Murray, E.、Lo, B.、Pollack, L.、Donelan, K.(2003)。Direct-toconsumer Advertising: Physicians' Views of Its Effects on Quality of Care and the Doctor-patient Relationship。Journal of the American Board Practice,16,513-524。 |
16. | Bell, R. A.、Kravitz, R. L.、Wikes, M. S.(1999)。Direct-to-consumer Prescription Drug Advertising and the Public。Journal of General Internal Medicine,14,651-657。 |
17. | Holmer, A. F.(1999)。Direct-to-Consumer Prescription Drug Advertising Builds Bridges between Patients and Physicians。JAMA: The Journal of the American Medical Association,281,380-382。 |
18. | Hogle, L. F.(2005)。Enhancement Technologies and the Body。Annual Review of Anthropology,34,695-716。 |
19. | Wick, J. Y.(2002)。Enhancing Life or Eradicating Ugliness? Lifestyle Drugs。Journal of Managed Care Pharmacy,8,15-20。 |
20. | DeCamp, M.(2002)。Ethics and the Physician-patient Relationship: Medico-moral Consequences of Commodification。Einstein Quarterly Journal Medicine,19,135-138。 |
21. | (1998)。Go on, It's Good for You [Editorial]。The Economist,348,51-52。 |
22. | Mintzes, B.、Barer, M. L.、Kravitz, R. L.(2003)。How Does Direct-to-consumer Advertising (DTCA) Affect Prescribing? A Survey in Primary Care Environments with and without Legal DTCA。Canadian Medical Association Journal,169,405-412。 |
23. | Smith, R.(2002)。Insearch of "Non-disease"。British Medical Journal,324,883-885。 |
24. | Garg, R. K.、Khaishgi, A.、Dandona, P.(1999)。Is Management of Impotence with Sildenafil Changing Clinical Practice?。The Lancet,353,375-376。 |
25. | Atkinson, T.(2002)。Lifestyle Drug Market Booming。Nature Medicine,8,909。 |
26. | Young, S. N.(2003)。Lifestyle Drugs, Mood, Behavior and Cognition。Journal of Psychiatry & Neuroscience,28,87-89。 |
27. | Mitrany, D.(2001)。Lifestyle Drugs: Determining Their Value and Who Should Pay。Pharmacoeconomics,19(1/2),441-448。 |
28. | Lexchin, J.(2001)。Lifestyle Drugs: Issues for Debate。Canadian Medical Association Journal,164(10),1449-1451。 |
29. | Flower, R.(2004)。Lifestyle Drugs: Pharmacology and the Social Agenda。Trends in Pharmacological Sciences,25,182-185。 |
30. | Gilbert, D.、Walley, T.、New, B.(2000)。Lifestyle Medicines。British Medical Journal,321,1341-1344。 |
31. | Walley, T.(2002)。Lifestyle Medicines and the Elderly。Drugs and Aging,19,163-168。 |
32. | Phillips, C. B.(2006)。Medicine Goes to School: Teachers as Sickness Brokers for ADHD。PLoS Medicine,3,182。 |
33. | Martin, Emily(2000)。Mind-body Problems AES Presidential Address: Mind-body Problems。American Ethnologist,27(3),569-590。 |
34. | Deckard, G. J.(1995)。Physician Responses to a Managed Environment: A Perceptual Paradox。Health Care Management Review,20,40-46。 |
35. | Ubel, P. A.、Goold, S.(1997)。Recognizing Bedside Rationing: Clear Cases and Tough Calls。Archives of Internal Medicine,126,74-80。 |
36. | Moynihan, R.、Heath, I.、Henry, D.、Gotzsche, P. C.(2002)。Selling Sickness: The Pharmaceutical Industry and Disease Mongering Commentary: Medicalisation of Risk Factors。British Medical Journal,324,886-891。 |
37. | Relman, A. S.(1983)。The Future of Medical Practice。Health Affairs,2,5-19。 |
38. | Frankel, S.、Ebrahim, S.、Davey, Smith G.(2000)。The Limits to Demand for Health Care。British Medical Journal,321,40-45。 |
39. | Relman, A. S.(1980)。The New Medical-industrial Complex。The New England Journal of Medicine,303,963-970。 |
40. | Møldrup, C.(2004)。The Use of the Terms 'Lifestyle Medicines' or 'Lifestyle Drugs'。Pharmacy World and Science,26,193-196。 |
41. | Moynihan, R.、Smith, R.(2002)。Too Much Medicine: Almost Certainly。British Medical Journal,324,859-860。 |
42. | Klein, R.、Sturm, H.(2002)。Viagra: A Success Story for Rationing?。Health Affairs,21,177-187。 |
43. | Overman, S.(1998)。Warning: Viagra May Cause Headaches for Health Insurers。Human Resources Magazine,43,104-109。 |